| 105712-4 | N,N-Dimethylpentylone/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 105713-2 | Alpha-Pyrrolidinoisohexanophenone/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 105714-0 | Fluorexetamine/2-Fluoro-2-Oxo-PCE (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 105715-7 | Fluorexetamine/2-Fluoro-2-Oxo-PCE (Urine, confirmatory method) | DRUG/TOX |
| 105716-5 | Fluorexetamine/2-Fluoro-2-Oxo-PCE (Urine, confirmatory method) | DRUG/TOX |
| 105717-3 | Bromazolam (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 105718-1 | Bromazolam/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 105719-9 | Bromazolam (Urine, confirmatory method) | DRUG/TOX |
| 10572-6 | Duration^post ejaculation | FERT |
| 105720-7 | Flubromazepam (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 105721-5 | Flubromazepam/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 105722-3 | Desalkylgidazepam (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 105723-1 | Desalkylgidazepam/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 105724-9 | Desalkylgidazepam (Urine, confirmatory method) | DRUG/TOX |
| 105725-6 | Influenza virus A+B RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105726-4 | Parainfluenza virus RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105727-2 | Parainfluenza virus 1 RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105728-0 | Parainfluenza virus 2 RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105729-8 | Parainfluenza virus 3 RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 10573-4 | Ferning in Cervical mucus | FERT |
| 105730-6 | Parainfluenza virus 4 RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105731-4 | Human metapneumovirus RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105732-2 | Rhinovirus RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105733-0 | Human coronavirus RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105734-8 | Human coronavirus 229E+HKU1+NL63+OC43 RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105735-5 | Human coronavirus NL63 RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105736-3 | Human coronavirus OC43 RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105737-1 | Human bocavirus 1+2+3+4 DNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105738-9 | Enterovirus RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 105739-7 | Cytomegalovirus DNA in Pericardial fluid (qualitative, naa with probe detection) | MICRO |
| 10574-2 | Fructose (Semen) | CHEM |
| 105740-5 | Adenovirus DNA in Pericardial fluid (qualitative, naa with probe detection) | MICRO |
| 105741-3 | Epstein Barr virus DNA in Pericardial fluid (qualitative, naa with probe detection) | MICRO |
| 105742-1 | Epstein Barr virus DNA (viral load) in Pericardial fluid (naa with probe detection) | MICRO |
| 105743-9 | Herpes virus 6 DNA in Pericardial fluid (qualitative, naa with probe detection) | MICRO |
| 105744-7 | Parvovirus B19 DNA in Pericardial fluid (qualitative, naa with probe detection) | MICRO |
| 105745-4 | Enterovirus RNA in Skin (qualitative, naa with probe detection) | MICRO |
| 105746-2 | Herpes virus 6 DNA in Skin (qualitative, naa with probe detection) | MICRO |
| 105747-0 | Adenovirus DNA in Urethra (qualitative, naa with probe detection) | MICRO |
| 105748-8 | SARS-CoV-2 (COVID-19) RNA in Tracheal aspirate (qualitative, naa with probe detection) | MICRO |
| 105749-6 | SARS-CoV-2 (COVID-19) RNA in Bronchoalveolar lavage (qualitative, naa with probe detection) | MICRO |
| 10575-9 | Gamma glutamyl transferase (Semen) | FERT |
| 105750-4 | Lactose challenge (methane breath test) panel - Exhaled gas | PANEL.CHAL |
| 105751-2 | Lactose challenge panel-hydrogen - Exhaled gas | PANEL.CHAL |
| 105752-0 | Reduction in clot strength (Blood) | COAG |
| 105753-8 | Maximum clot strength amplitude (Blood, maximum amplitude kaolin+tissue factor induced post heparin neutralization) | COAG |
| 105754-6 | Maximum clot strength amplitude (Blood, maximum amplitude tissue factor induced+platelet glycoprotein iib-iiia receptor inhibited post heparin neutralization) | COAG |
| 105755-3 | M. tuberculosis rrs gene kanamycin high level resistance mutation in Isolate or Specimen (molecular genetics method nominal) | MOLPATH.MUT |
| 105756-1 | Mycobacterium tuberculosis eis gene mutations in Isolate or Specimen (molecular genetics method nominal) | MOLPATH.MUT |
| 105757-9 | Mycobacterium tuberculosis embC-embA promoter region gene ethambutol resistance mutation in Isolate or Specimen (molecular genetics method nominal) | MOLPATH.MUT |